Lawrence A. Tabak

From Wikipedia, the free encyclopedia
Lawrence A. Tabak
Lawrence Tabak.jpg
Tabak in 2019
Director of the National Institutes of Health
Acting
Assumed office
December 20, 2021
PresidentJoe Biden
DeputyTara A. Schwetz (acting)
Preceded byFrancis Collins
Principal Deputy Director of the National Institutes of Health
Assumed office
August 2010
Preceded byRaynard S. Kington
Succeeded byTara A. Schwetz (acting)
Director of the National Institute of Dental and Craniofacial Research
In office
September 2000 – August 2010
Preceded byHarold C. Slavkin
Succeeded byA. Isabel Garcia (acting)
Personal details
EducationCity College of New York (BS)
Columbia University (DDS)
University at Buffalo (PhD)

Lawrence A. Tabak is an American dentist and biomedical scientist serving as the acting director of the National Institutes of Health. He is the principal deputy director of the National Institutes of Health. Tabak was director of the National Institute of Dental and Craniofacial Research from 2000 to 2010.

Education[]

Tabak is a native of Brooklyn, New York. He received his undergraduate degree from City College of New York, his D.D.S. from Columbia University College of Dental Medicine, and both a Ph.D. and certificate of proficiency in endodontics from the University at Buffalo.[1] Tabak's 1981 dissertation was titled Structural and functional studies of monkey salivary mucin.[2]

Career[]

Tabak was the senior associate dean for research and professor of dentistry and biochemistry and biophysics in the University of Rochester Medical Center. He was a National Institutes of Health MERIT Award recipient, Tabak's major research focus has been on the structure, biosynthesis and function of glycoproteins. He continues work in this area, maintaining an active research laboratory within the NIH intramural program in addition to his administrative duties.[3]

Tabak served as the director of the National Institute of Dental and Craniofacial Research from 2000 to 2010. He served as acting NIH deputy director in 2009 and was the acting director of the Division of Program Coordination, Planning, and Strategic Initiatives.[1] Tabak succeeded Raynard S. Kington as the NIH principal deputy director in August 2010.[1] Tabak serves as the deputy ethics counselor of the NIH.[3]

On December 20, 2021, Tabak succeeded Francis Collins as acting director of the NIH. Tara A. Schwetz will serve in Tabak's previous role as the acting principal deputy director of the NIH.[4]

Awards and honors[]

Tabak is an elected member the National Academy of Medicine.[3] He is a Fellow of the American Association for the Advancement of Science.[1]

References[]

  1. ^ a b c d "Lawrence A. Tabak named principal deputy director NIH". National Institutes of Health (NIH). 2015-08-26. Retrieved 2021-10-05.Public Domain This article incorporates text from this source, which is in the public domain.
  2. ^ Tabak, Lawrence A. (1981). Structural and functional studies of monkey salivary mucin (Ph.D. thesis). State University of New York at Buffalo. OCLC 8395645.
  3. ^ a b c "Lawrence A. Tabak, D.D.S., Ph.D." National Institutes of Health (NIH). 2015-08-07. Retrieved 2021-10-05.Public Domain This article incorporates text from this source, which is in the public domain.
  4. ^ "Longtime No. 2 at NIH Tapped to Serve as Acting Director (1)". Bloomberg Law. December 9, 2021. Retrieved 2021-12-23.{{cite web}}: CS1 maint: url-status (link)
Public Domain This article incorporates public domain material from websites or documents of the National Institutes of Health.

External links[]

Retrieved from ""